Literature DB >> 21481180

Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses.

F A Hanzu1, M Palomo, S G Kalko, M Parrizas, M Garaulet, G Escolar, R Gomis, M Diaz-Ricart.   

Abstract

BACKGROUND: Obesity is associated with an increased atherothrombotic morbidity/mortality risk. However, there is no direct evidence of subclinical activation of the endothelium in obese subjects without other major cardiometabolic risk factors.
OBJECTIVES: We applied a translational approach to investigate endothelial activation occurring in response to the components secreted by visceral and subcutaneous adipose tissue and their corresponding cell fractions obtained from obese subjects without other major cardiometabolic risk factors, as compared with non-obese controls.
METHODS: Fat pads and cell fractions were incubated with serum-free medium to obtain their secretomes, which were analyzed by protein arrays. Endothelial cells (ECs) were exposed to the different secretomes to evaluate changes in gene expression, composition and reactivity of the extracellular matrix (ECM), and cell growth and viability.
RESULTS: ECs incubated in the presence of obese secretomes displayed increased proliferation, altered cell morphology, augmented expression of VCAM-1, ICAM-1, and von Willebrand factor, and higher ECM reactivity towards circulating platelets. The visceral secretomes, especially the stromal one, induced the strongest expression of these markers, together with a more reactive ECM. These changes occurred through nuclear factor-κB (NF-κB) activation.
CONCLUSION: This is the first translational study demonstrating that the cytokines secreted by the adipose tissue from obese individuals without other major cardiometabolic complications have a hazardous effect on the endothelium, through activation of the NF-κB pathway.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481180     DOI: 10.1111/j.1538-7836.2011.04285.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  17 in total

1.  What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance.

Authors:  Marta Palomo; Enrique Mir; Montse Rovira; Ginés Escolar; Enric Carreras; Maribel Diaz-Ricart
Journal:  Blood       Date:  2016-01-11       Impact factor: 22.113

2.  miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome.

Authors:  Rebecca Hutcheson; Russell Terry; Brenda Hutcheson; Rashmi Jadhav; Jennifer Chaplin; Erika Smith; Robert Barrington; Spencer D Proctor; Petra Rocic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-03       Impact factor: 4.733

Review 3.  Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?

Authors:  Petra Rocic
Journal:  Vascul Pharmacol       Date:  2012-02-09       Impact factor: 5.773

4.  Systems proteomics for translational network medicine.

Authors:  D Kent Arrell; Andre Terzic
Journal:  Circ Cardiovasc Genet       Date:  2012-08-01

5.  Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery.

Authors:  Pilar Taura; Eva Rivas; Graciela Martinez-Palli; Annabel Blasi; Juan Carlos Holguera; Jaume Balust; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2013-09-17       Impact factor: 4.584

6.  Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.

Authors:  Tracy Dodd; Luke Wiggins; Rebecca Hutcheson; Erika Smith; Alla Musiyenko; Brenda Hysell; James C Russell; Petra Rocic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

7.  Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation.

Authors:  Lora C Bailey-Downs; Zsuzsanna Tucsek; Peter Toth; Danuta Sosnowska; Tripti Gautam; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-12-03       Impact factor: 6.053

Review 8.  The hematologic consequences of obesity.

Authors:  Johanna C Purdy; Joseph J Shatzel
Journal:  Eur J Haematol       Date:  2020-12-13       Impact factor: 2.997

9.  Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.

Authors:  Sergi Torramade-Moix; Marta Palomo; Manel Vera; Didac Jerez; Ana Belen Moreno-Castaño; M Urooj Zafar; Jordi Rovira; Fritz Diekmann; Joan Carles Garcia-Pagan; Gines Escolar; Aleix Cases; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06       Impact factor: 3.727

Review 10.  Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

Authors:  Pedro Castro; Marta Palomo; Ana Belen Moreno-Castaño; Sara Fernández; Sergi Torramadé-Moix; Georgina Pascual; Julia Martinez-Sanchez; Edward Richardson; Adrián Téllez; Josep M Nicolas; Enric Carreras; Paul G Richardson; Juan José Badimon; Gines Escolar; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-07       Impact factor: 3.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.